Natco Pharma launches generic drug with 180-day exclusivity in US

Natco Pharma has launched Bosentan tablets, a generic version of Tracleer, in the US for treating pulmonary arterial hypertension in young patients. This launch comes with 180-day exclusivity. Lupin Ltd. is Natco's marketing partner for this product. The drug had estimated sales of USD 10 million in the US for the 12 months ended June this year.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/J5HvGMB
via IFTTT